Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Pedro M. Folegatti | Researchclopedia

Back to researchers

Pedro M. Folegatti

Churchill Hospital ORCID

61

Works

15,150

Citations

27

h-index

37

i10-index

Research Topics

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Respiratory viral infections research

Affiliations

University of London2017–2017

Churchill Hospital2025–2025

Public Health England2021–2021

University of Oxford2017–2025

London School of Hygiene & Tropical Medicine2017–2017

Top Works

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey,Sue Ann Costa Clemens,et al.

20204,982 citations

Malaria Research and Control

Mosquito-borne diseases and control

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti,Katie Ewer,et al.

20202,607 citations

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng,Daniel J. Phillips,et al.

20211,231 citations

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Folegatti, PM,Angela M. Minassian,et al.

20201,212 citations

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey,Sue Ann Costa Clemens,et al.

20211,203 citations

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary,Tanya Golubchik,et al.

2021651 citations

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie Ewer,Jordan R. Barrett,et al.

2020638 citations

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti,Katie Ewer,et al.

2020536 citations

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett,Sandra Belij‐Rammerstorfer,et al.

2020336 citations